Home › NCT07247474
Triple EIT (Electrical Impedance Tomography)
Characterizing the Evolution of Neonatal Lung Disease Throughout Infancy and Childhood Using Electrical Impedance Tomography: A Pilot Study
Who can join
2 Weeks – 25 Years · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * 2 weeks to 25 years of age * evidence of cardiopulmonary disease including, but not limited to: 1. Post-prematurity respiratory disease 2. Congenital diaphragmatic hernia 3. Pulmonary Hypertension 4. Congenital heart disease 5. Respiratory failure 6. Neuromuscular Disease 7. Developmental or congenital lung disease OR matched healthy controls (born at term gestation (\>36 weeks gestational age) with no cardiopulmonary disease) Exclusion Criteria: * \<2 weeks of age * Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved) * No informed consent * Pregnant or lactating * Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)
About the study
This study plans to learn more about ways to look at participant's lungs using new machines called Electrical Impedance Tomography (EIT). The EIT does not use harmful radiation like CT or x-ray. It is read through electrodes like using EKG reading heartbeats.
The investigators want to compare the results of patients who have chronic respiratory disease to patients without chronic respiratory disease to learn more about lung structure and composition.
What is being tested
- Electrical impedance tomography (EIT) (device)
Sponsor: University of Colorado, Denver · Participants: 140 · Started: Jan 30, 2026
Contact the study team
- Katelyn Enzer, MD · Phone: 7207779137
- Allison Keck, BS · Phone: 720-777-0734
Official record on ClinicalTrials.gov — NCT07247474
Locations in the U.S.
| Colorado | Children's Hospital Colorado, Aurora |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.